![Anna Abram, Senior Advisor, Health Care Policy and Legislation | Akin, Elite Global Law Firm | Akin Gump Strauss Hauer & Feld LLP Anna Abram, Senior Advisor, Health Care Policy and Legislation | Akin, Elite Global Law Firm | Akin Gump Strauss Hauer & Feld LLP](https://www.akingump.com/a/web/mWhJyaem8q29mbBujH7J9W/4Sqp1V/abram_anna_2160x1540.jpg)
Anna Abram, Senior Advisor, Health Care Policy and Legislation | Akin, Elite Global Law Firm | Akin Gump Strauss Hauer & Feld LLP
![NIIMBL on X: "@US_FDA Deputy Commissioner for Policy, Legislation, and Analysis, Anna Abram, discusses FDA support for the development of advanced manufacturing technologies. @MFGUSA https://t.co/XA8SD8WEJR" / X NIIMBL on X: "@US_FDA Deputy Commissioner for Policy, Legislation, and Analysis, Anna Abram, discusses FDA support for the development of advanced manufacturing technologies. @MFGUSA https://t.co/XA8SD8WEJR" / X](https://pbs.twimg.com/media/DdUvXPLX0AADoQP.jpg)
NIIMBL on X: "@US_FDA Deputy Commissioner for Policy, Legislation, and Analysis, Anna Abram, discusses FDA support for the development of advanced manufacturing technologies. @MFGUSA https://t.co/XA8SD8WEJR" / X
![MDIC در X: «#FDA 's Anna Abram discusses Real World Evidence at @MDICOnline Annual Public Forum #MDIC2017 https://t.co/X8mxdFnwl9» / X MDIC در X: «#FDA 's Anna Abram discusses Real World Evidence at @MDICOnline Annual Public Forum #MDIC2017 https://t.co/X8mxdFnwl9» / X](https://pbs.twimg.com/media/DLN4rbXUMA0EEIG.jpg)